Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$91.3 - $115.05 $20,999 - $26,461
-230 Reduced 10.68%
1,924 $210,000
Q3 2023

Nov 09, 2023

SELL
$97.55 - $135.91 $6,633 - $9,241
-68 Reduced 3.06%
2,154 $217,000
Q1 2023

May 05, 2023

BUY
$89.75 - $107.27 $199,424 - $238,353
2,222 New
2,222 $231,000
Q2 2022

Aug 05, 2022

SELL
$88.23 - $154.18 $178,224 - $311,443
-2,020 Closed
0 $0
Q1 2022

May 09, 2022

SELL
$121.88 - $150.0 $11,456 - $14,100
-94 Reduced 4.45%
2,020 $300,000
Q4 2021

Feb 10, 2022

BUY
$129.86 - $157.03 $274,524 - $331,961
2,114 New
2,114 $300,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $1.86B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Prudent Man Advisors, LLC Portfolio

Follow Prudent Man Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudent Man Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudent Man Advisors, LLC with notifications on news.